FDA clears NeuroRPM, Apple Watch app to monitor daily symptoms
NeuroRPM, an artificial intelligence (AI)-powered app designed to continuously monitor hallmark symptoms of Parkinson’s disease has been cleared for…
Articles by Patricia Inácio, PhD
CND, Beth Israel team on diagnostic tests for neurodegenerative diseases
Note: This story was updated March 24, 2023, to correct the name of CND Life Sciences. CND Life Sciences…
Frailty identified as risk factor for Parkinson’s disease in study
People with physical frailty have a nearly twofold higher risk of developing Parkinson’s disease than those who aren’t frail,…
Cure Parkinson’s and VAI renew support of Parkinson’s trials
Cure Parkinson’s and the Van Andel Institute (VAI) will continue to support a global program that seeks to…
Prebiotic bar, eaten daily, helps to ease inflammation in patients’ gut
Eating a tailored prebiotic fiber bar — meant to help nourish good bacteria in the gut — for 10 days…
‘Cue Band’ to counter drooling enrolling patients for at-home testing
Parkinson’s UK is continuing to support work into a wearable device — called Cue Band — aiming to lessen chronic…
Resveratrol oral formulation Jotrol shows gains in mouse model
Jotrol, Jupiter Neuroscience’s oral formulation of resveratrol, significantly improved muscle strength, motor coordination, and behavior in a mouse model…
Incision-free ‘surgery’ lowers hard-to-treat Parkinson’s motor symptoms
Insightec’s incision-free brain “surgery” technology — Exablate Neuro — leads to significant and sustained reductions in tremors, mobility problems,…
Lipophilic statins linked to lower Parkinson’s risk in women: Study
Women using a specific type of blood cholesterol-lowering medication, called lipophilic statins, for at least five years may have a…
NRG awarded second $500K grant for its DMT program
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a second $500,000 grant to NRG Therapeutics supporting more…